Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00282516 · ClinicalTrials.gov registry record · NA
Asthma In-Home Monitoring (AIM) Trial
A NA study of Mild, Moderate and Severe Persistent Asthma as Defined by NHLBI-2 Guidelines, sponsored by Tripler Army Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT00282516 is a NA study of Mild, Moderate and Severe Persistent Asthma as Defined by NHLBI-2 Guidelines that has completed, run by Tripler Army Medical Center. The registered enrollment target is 120 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00282516, a NA study of Mild, Moderate and Severe Persistent Asthma as Defined by NHLBI-2 Guidelines, has completed, sponsored by Tripler Army Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
OBJECTIVE: Determine whether home asthma telemonitoring using store-and-forward technology improves outcomes when compared to in-person, office-based visits.
Conditions Studied
Interventions
- PROCEDURE In-home telemonitoring of pediatric patients with persistent asthma
Study Locations (1)
Hawaii
- Tripler Army Medical Center - Tripler AMC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2003-04 |
| Est. Completion | 2004-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00282516
The ClinicalTrials.gov registry entry for NCT00282516 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tripler Army Medical Center, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Mild, Moderate and Severe Persistent Asthma as Defined by NHLBI-2 Guidelines appearing as the primary indexed condition, and to 1 intervention - of which In-home telemonitoring of pediatric patients with persistent asthma is the first listed.
NCT00282516 reports 1 study location spanning 1 distinct geographic area - top geographies include Hawaii.
Frequently Asked Questions
What is clinical trial NCT00282516 about?
NCT00282516 is a clinical study titled "Asthma In-Home Monitoring (AIM) Trial". OBJECTIVE: Determine whether home asthma telemonitoring using store-and-forward technology improves outcomes when compared to in-person, office-based visits.
What is the current status of trial NCT00282516?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2003-04. Estimated completion is 2004-04.
What conditions does trial NCT00282516 study?
This clinical trial studies the following conditions: Mild, Moderate and Severe Persistent Asthma as Defined by NHLBI-2 Guidelines.
What interventions are being tested in trial NCT00282516?
The interventions under investigation include: In-home telemonitoring of pediatric patients with persistent asthma (PROCEDURE).
Who is sponsoring clinical trial NCT00282516?
This trial is sponsored by Tripler Army Medical Center, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00282516 being conducted?
This trial has 1 study location across Hawaii. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.